Your browser doesn't support javascript.
loading
Clinical Outcomes of Non-Stent Based Interventions for Symptomatic Below-the-Knee Peripheral Artery Disease in the Excellence in Peripheral Artery Disease (XLPAD) Registry.
Sayfo, Sameh; Rosol, Zachary P; Vazquez, David Fernandez; Mamawala, Mufaddal; Bruneman, Blake M; Weideman, Sarah G; Adelman, Kennedy S; Jeong, Minseob; Ramanan, Bala; Tsai, Shirling; Shammas, Nicolas W; Monteleone, Peter P; Nanjundappa, Aravinda; Chu, Hung B; Smith, Bertram L; Grimsley, Bradley R; Hohmann, Stephen E; Vasquez, Javier; Metzger, Chris; Das, Tony S; Gable, Dennis R; Eidt, John F; Banerjee, Subhash.
Affiliation
  • Sayfo S; Baylor Scott & White Heart Hospital Plano, Plano, TX.
  • Rosol ZP; Baylor University Medical Center, Dallas, TX; Baylor Heart and Vascular Hospital, Dallas, TX.
  • Vazquez DF; Baylor Scott & White Research Institute, Dallas, TX.
  • Mamawala M; Baylor Scott & White Research Institute, Dallas, TX.
  • Bruneman BM; Baylor Scott & White Research Institute, Dallas, TX.
  • Weideman SG; Baylor Scott & White Research Institute, Dallas, TX.
  • Adelman KS; Baylor Scott & White Research Institute, Dallas, TX.
  • Jeong M; Baylor Scott & White Research Institute, Dallas, TX.
  • Ramanan B; University of Texas Southwestern Medical Center, Dallas, TX; Veterans Affairs North Texas Health Care System, Dallas, TX.
  • Tsai S; University of Texas Southwestern Medical Center, Dallas, TX; Veterans Affairs North Texas Health Care System, Dallas, TX.
  • Shammas NW; Midwest Cardiovascular Research Foundation, Davenport, IA.
  • Monteleone PP; University of Texas at Austin Dell School of Medicine, Austin, TX.
  • Nanjundappa A; Cleveland Clinic Foundation, Cleveland, OD.
  • Chu HB; Baylor University Medical Center, Dallas, TX; Baylor Heart and Vascular Hospital, Dallas, TX.
  • Smith BL; Baylor University Medical Center, Dallas, TX; Baylor Heart and Vascular Hospital, Dallas, TX.
  • Grimsley BR; Baylor University Medical Center, Dallas, TX; Baylor Heart and Vascular Hospital, Dallas, TX.
  • Hohmann SE; Baylor University Medical Center, Dallas, TX; Baylor Heart and Vascular Hospital, Dallas, TX.
  • Vasquez J; Baylor University Medical Center, Dallas, TX; Baylor Heart and Vascular Hospital, Dallas, TX.
  • Metzger C; Ohio Health Physician Group, Columbus, OH.
  • Das TS; Baylor Scott & White Heart Hospital Plano, Plano, TX.
  • Gable DR; Baylor Scott & White Heart Hospital Plano, Plano, TX.
  • Eidt JF; Baylor University Medical Center, Dallas, TX; Baylor Heart and Vascular Hospital, Dallas, TX.
  • Banerjee S; Baylor University Medical Center, Dallas, TX; Baylor Heart and Vascular Hospital, Dallas, TX. Electronic address: Subhash.Banerjee@BSWHealth.org.
Am J Cardiol ; 2024 Aug 05.
Article in En | MEDLINE | ID: mdl-39111561
ABSTRACT

BACKGROUND:

For endovascular treatment of below-the-knee (BTK) peripheral artery disease (PAD), independently adjudicated real-world outcomes comparing non-stent (balloon angioplasty or PTA and adjunctive treatment) with or without a concomitant ipsilateral femoropopliteal (FP) artery intervention are scarce.

METHODS:

1060 patients from the multicenter XLPAD Registry between 2006-2021 with non-stent based BTK PAD intervention are included. PRIMARY

OUTCOME:

1-year incidence of major adverse limb events (MALE), a composite of all-cause death, any amputation, or clinically driven repeat revascularization.

RESULTS:

566 patients underwent BTK and 494 BTK + FP interventions; 72% men, with mean age 68.4 ± 10.9 years. Diabetes mellitus is more prevalent in BTK only group (76.5% vs. 69%, p=0.006). Mean Rutherford class 4.2 ± 1.18; chronic limb threatening ischemia is more frequent in the BTK group (55.3% vs. 49%, p=0.040). Moderate to severe calcification is higher in BTK + FP (21.2% vs. 27.1%, p=0.024), so is lesion length (110.6 ± 77.3 vs. 135.4 ± 86.3 mm; p<0.001). Nearly, 81% lesions are treated with PTA. DCB (1.6% vs 14%, p<0.001) and atherectomy (38% vs. 58.5%; p<0.001) use is greater in BTK + FP. Procedural success is higher in BTK + FP group (86% vs. 91%, p=0.009), with amputation being the most common complication at 3.3% ≤30 days. One-year MALE (21.2% vs. 22.3%, p=0.675) and mortality (4.6% vs. 3.4%; p=0.3) are similar across BTK and BTK + FP groups.

CONCLUSION:

Non-stent treatment for BTK PAD with concomitant FP intervention leads to high procedural success and similar rates of 1-year MALE compared with isolated BTK intervention. CONDENSED ABSTRACT The vast majority of below-the-knee (BTK) peripheral artery disease (PAD) interventions are performed with balloon angioplasty. Presence of inflow femoropopliteal (FP) PAD in patients undergoing BTK interventions can affect the outcome of the procedure. This report explores the immediate procedural success and major adverse limb events at 1 year following balloon angioplasty treatment for isolated BTK and in those undergoing an additional FP PAD intervention.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Am J Cardiol Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Am J Cardiol Year: 2024 Document type: Article